Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4542213017 | Margetuximab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4542214011 | Product containing margetuximab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Margetuximab-containing product in parenteral dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
Margetuximab-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Margetuximab-containing product in parenteral dose form | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
Margetuximab-containing product in parenteral dose form | est un(e) (attribut) | Margetuximab-containing product | true | Inferred relationship | Some | ||
Margetuximab-containing product in parenteral dose form | a pour principe actif (attribut) | Margetuximab (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only margetuximab in parenteral dose form (medicinal product form) | est un(e) (attribut) | True | Margetuximab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets